This guideline includes statements and recommendations based on available evidence about the management of women at high or potentially high risk of ovarian cancer.[a] The guideline aims to provide health professionals with information designed to assist in making management recommendations for improved patient outcomes.
A clinical practice guideline developed by National Breast And Ovarian Cancer Centre (NBOCC)*
This document supplements guideline recommendation about risk-reducing surgery (page 37) contained in the National Breast Cancer Centre (NBCC) and Australian Cancer Network (ACN), Clinical practice guidelines for the management of women with epithelial ovarian cancer, 2004.
Incorporates published evidence to April 2010
- Australian Society of Gynaecological Oncologists (ASGO)
- The Royal Australian and New Zealand College of Obstetricians and Gynaecologists
- The Royal College of Pathologists of Australia (RCPA)
© Cancer Australia 2011
* In July 2011, National Breast and Ovarian Cancer Centre (NBOCC) amalgamated with Cancer Australia to form a single national agency, Cancer Australia, to provide leadership in cancer control and improve outcomes for Australians affected by cancer.
[a] Where recommendations apply specifically to either high-risk or potentially high-risk women this has been noted.
|Guideline Topic||Ovarian cancer|
|Cancer Types||Ovarian cancer|
This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.